sodium phenylacetate and sodium benzoate injection, solution, concentrate
trigen laboratories, llc - sodium phenylacetate (unii: 48n6u1781g) (phenylacetic acid - unii:er5i1w795a), sodium benzoate (unii: oj245fe5eu) (benzoic acid - unii:8skn0b0mim) - sodium phenylacetate 100 mg in 1 ml - sodium phenylacetate and sodium benzoate injection, 10%/10% is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. during acute hyperammonemic episodes, arginine supplementation, caloric supplementation, dietary protein restriction, hemodialysis, and other ammonia lowering therapies should be considered [see warnings and precautions (5) ]. none. pregnancy category c. animal reproduction studies have not been conducted with sodium phenylacetate and sodium benzoate injection, 10%/10%. it is not known whether sodium phenylacetate and sodium benzoate injection, 10%/10% can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. thus, sodium phenylacetate and sodium benzoate injection, 10%/10% should be given to a pregnant woman only if clearly needed. it is not known whether sodium phenylacetate, sodium benzoate, or their
potassium chloride 0.3% (potassium 40mmol/1litre) / glucose 4% / sodium chloride 0.18% infusion 1litre viaflex bags
potassium 40mmol/1litre) / glucose 4% / sodium chloride 0.18% infusion 1litre viaflex bags (baxter healthcare ltd - glucose anhydrous; potassium chloride; sodium chloride - infusion - 40mg/1ml ; 3mg/1ml ; 1.8mg/1ml
potassium chloride 0.3% (potassium 20mmol/500ml) / glucose 4% / sodium chloride 0.18% infusion 500ml bags
potassium 20mmol/500ml) / glucose 4% / sodium chloride 0.18% infusion 500ml bags (baxter healthcare ltd - glucose anhydrous; potassium chloride; sodium chloride - infusion - 40mg/1ml ; 3mg/1ml ; 1.8mg/1ml
potassium chloride 15% (potassium 20mmol/10ml) solution for infusion 10ml ampoules
potassium 20mmol/10ml) solution for infusion 10ml ampoules (advanz pharma - potassium chloride - solution for infusion - 150mg/1ml
potassium chloride 0.3% (potassium 20mmol/500ml) / glucose 4% / sodium chloride 0.18% infusion 500ml macoflex bags
potassium 20mmol/500ml) / glucose 4% / sodium chloride 0.18% infusion 500ml macoflex bags (maco pharma (uk) ltd - glucose anhydrous; potassium chloride; sodium chloride - infusion - 40mg/1ml ; 3mg/1ml ; 1.8mg/1ml
potassium chloride 0.3% (potassium 40mmol/1litre) / glucose 4% / sodium chloride 0.18% infusion 1litre macoflex bags
potassium 40mmol/1litre) / glucose 4% / sodium chloride 0.18% infusion 1litre macoflex bags (maco pharma (uk) ltd - glucose anhydrous; potassium chloride; sodium chloride - infusion - 40mg/1ml ; 3mg/1ml ; 1.8mg/1ml
potassium chloride 0.15% (potassium 10mmol/500ml) / glucose 10% / sodium chloride 0.18% solution for infusion 500ml bottles
potassium 10mmol/500ml) / glucose 10% / sodium chloride 0.18% solution for infusion 500ml bottles (special order - glucose anhydrous; potassium chloride; sodium chloride - solution for infusion - 100mg/1ml ; 1.5mg/1ml ; 1.8mg/1ml
potassium chloride 0.3% (potassium 20mmol/500ml) / glucose 10% / sodium chloride 0.45% solution for infusion 500ml bottles
potassium 20mmol/500ml) / glucose 10% / sodium chloride 0.45% solution for infusion 500ml bottles (special order - sodium chloride; potassium chloride; glucose monohydrate - solution for infusion - 4.5mg/1ml ; 3mg/1ml ; 100mg/1ml
potassium chloride 0.3% (potassium 40mmol/1litre) / glucose 5% / sodium chloride 0.45% infusion 1litre bags
potassium 40mmol/1litre) / glucose 5% / sodium chloride 0.45% infusion 1litre bags (special order - glucose anhydrous; potassium chloride; sodium chloride - infusion - 50mg/1ml ; 3mg/1ml ; 4.5mg/1ml
sodium phenylacetate and sodium benzoate injection, solution, concentrate
ailex pharmaceuticals, llc - sodium phenylacetate (unii: 48n6u1781g) (phenylacetic acid - unii:er5i1w795a), sodium benzoate (unii: oj245fe5eu) (benzoic acid - unii:8skn0b0mim) - sodium phenylacetate 100 mg in 1 ml - sodium phenylacetate and sodium benzoate injection, 10%/10% is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. during acute hyperammonemic episodes, arginine supplementation, caloric supplementation, dietary protein restriction, hemodialysis, and other ammonia lowering therapies should be considered [see warnings and precautions (5) ]. none. pregnancy category c. animal reproduction studies have not been conducted with sodium phenylacetate and sodium benzoate injection, 10%/10%. it is not known whether sodium phenylacetate and sodium benzoate injection, 10%/10% can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. thus, sodium phenylacetate and sodium benzoate injection, 10%/10% should be given to a pregnant woman only if clearly needed. it is not known whether sodium phenylacetate, sodium benzoate, or their conjugation p